From July 1, 2021 to December 31, 2021, the company has repurchased 17,084,000 shares, representing 4.33% for HKD 37.25 million. With this, the company has completed the repurchase of 19,858,000 shares, representing 5.03% for HKD 43.9 million under the buyback announced on June 2, 2021.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |